Furthermore, the osteoprotegerin (OPG)/Receptor Activator of Nuclear Factor B Ligand (RANKL) pathway is regulated by GLP-1RAs, increasing the OPG/RANKL ratio to inhibit osteoclast formation and promote bone formation by upregulating osteogenic genes like OC, COL1, Runx2, and ALP [120, 121]
Despite these promising findings, long-term clinical data remains limited
Our study suggests that besides obesity and diabetes, GLP-1-agonists may also help in the treatment of alcohol and substance use disorders
Cardiovascular effects of testosterone replacement therapy in hypogonadal men: a systematic review of lipid profiles, inflammatory markers, and vascular function
doi: 10.1136/bmjopen-2011-000494
These injections can enhance energy levels, improve fat metabolism, and provide essential nutrients that help with overall wellness and weight management